Congenital pulmonary airway malformation (CPAM), formerly known as congenital cystic adenomatoid malformation (CCAM), is a congenital pulmonary disease that resembles bronchopulmonary sequestration. The disease is characterized by the replacement of usually an entire lobe of the lung with a cystic mass of abnormal lung tissue that does not function properly. Although CPAM has a good prognosis in most cases, there are still many mysteries worth exploring in the medical community as to why about one-third of patients experience cyanosis.
CPAM occurs in about 1 in 30,000 pregnancies. Although most fetuses develop healthily in this condition, in some extreme cases, the growth of the mass may compress the surrounding Lung tissue and heart. CPAM is divided into five types according to their different types. The most common type is type 1, which has larger cysts and a good prognosis. In contrast, type II cysts are smaller, often present with other significant abnormalities, and have a worse prognosis.
It was shown that 25% of patients with CPAM will develop cyanosis, pneumothorax, and increased respiratory distress (such as shortness of breath and intercostal retractions).
The occurrence of cyanosis is directly related to the oxygenation status of the blood in the lungs. In people with CPAM, abnormal lung tissue may prevent proper blood flow, preventing oxygen from entering the bloodstream, resulting in cyanosis. This means that this part of the lung tissue cannot carry out effective gas exchange and may affect heart function, causing the heart to not get enough oxygen, which in turn causes cyanosis.
CPAM is usually detected during prenatal ultrasound examinations and produces echogenic features including an echogenic mass in the fetal chest, a misaligned heart, a flat or protruding diaphragm, and visible lung tissue. Missing, etc. Through these tests, doctors are able to diagnose the condition and intervene early.
In most cases, people with CPAM have surgery after birth to remove the abnormal tissue to reduce the risk of future infection.
Surgery is usually performed before the baby is one year old, and advances in minimally invasive surgery now allow surgeons to safely remove these masses using very small incisions. Although most CPAM patients have a good survival rate, some CPAM that remain undetected for a long time occasionally transform into cancer. This has attracted the attention of the medical community and prompted many medical institutions to emphasize the importance of regular screening.
According to a 2023 retrospective study, the prognosis for patients with prenatally diagnosed CPAM is generally good. However, if fetal edema occurs, the survival rate decreases significantly. The risk is also reduced if hydrops fetalis does not develop before 26 weeks of gestation, highlighting the importance of early diagnosis and prompt treatment.
SummaryOne-third of CPAM patients experience cyanosis. Is there a deeper physiological and medical truth behind this?
Although many people with CPAM may not have many problems in their lives, the cyanosis phenomenon may reveal the potential risks and challenges of this disease. Because of this, how to prevent and diagnose early is worthy of further thinking and in-depth understanding by each of our medical personnel and the public.